HSD17B13 and metabolic dysfunction-associated steatohepatitis: Higher HSD17B13 expression was significantly observed in the livers with NASH or cirrhosis (Figure 1A), with the samples demonstrating IHC scores of 67.85 ± 1.37 in NASH and of 68.89 ± 1.71 in cirrhosis compared to the scores of 49.74 ± 4.13 found in normal livers (Figure 1A).